The future is now: AI-enabled RNA–LNP discovery

Bowen Li

11 April 2025

Interview

For the many and the few: bringing ASO therapies to both mainstream and nano-rare indications

Stanley Crooke

12 March 2025

Interview

Improving lipid nanoparticle formulations for targeted delivery of genome editors

Rohit Sharma

05 November 2024

Interview

Advancing delivery of RNA therapeutics with cationizable xenopeptides

Ernst Wagner

24 September 2024

Interview

Delving into the unknowns of mRNA-LNP formulation and characterization

Ramesh Marasini

15 July 2024

Interview

Taking a high-throughput approach to enhancing the target specificity and stability of nanoparticles

Chun-Wan Yen, Yuchen Fan

20 June 2024

Interview

Pushing the boundaries of siRNA targeting and delivery

Merle Fuchs

20 March 2024

Interview

Key challenges and future opportunities for LNP-based delivery

Julien Couture-Senécal

19 March 2024

Interview

Focusing on the fundamentals: what do and don’t we know about mRNA delivery?

Colin Pouton, Angus Johnston

04 March 2024

Interview

Pioneering nucleic acid breakthroughs for the world

Robert Langer

23 February 2024

Interview

Pushing the boundaries of nucleic acid delivery

John Lewis

23 February 2024

Interview

Targeting improved longevity and cancer through proteo-lipid vehicle delivery

Matthew Scholz

23 February 2024

Interview

Exploring the application of doggybone DNA to facilitate non-viral gene therapy delivery to hemophilia patients

Carol H Miao

20 July 2023

Interview

Expanding the potential of in vivo cell therapy with tLNP-RNAs (targeted lipid nanoparticle-RNA)

Adrian Bot

28 June 2023

Interview

Pushing the frontiers of mRNA formulation & delivery

Mohamed EH ElSayed

23 April 2023

Interview

Vaccines & beyond: a decade in mRNA delivery

Russell Johnson

30 January 2023

Interview